Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,029 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,160
Recruiting: 666
Ph III recruiting: 61
Growth YoY: +9.3%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (561)

clinicaltrialsPublishedShowing 851–900 of 1,150 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02767375	Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection(HAICAT)	unknown	Phase 2 / Phase 3	192	Peking University Cancer Hospital & InstituteOTHER	1	Aug 10, 2017	clinicaltrials
NCT03243916	Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC	unknown	N/A	40	Chinese PLA General HospitalOTHER	1	Aug 9, 2017